header("Content-type: text/html; charset=iso-8859-1"); ?>
Organization: Centers for Disease Control and Prevention (CDC)
Description: The Core Curriculum is intended for use as a self-study guide or reference manual for clinicians and other public health professionals caring for people with or at high risk for TB disease or infection. This chapter deals with treatment of TB disease.
Organization: Curry International Tuberculosis Center (CITC)
Year: Originally developed in February 2006 and updated in November 2009
Description: This webinar provides information on how to manage treatment of tuberculosis (TB). A question and answer session, a printable PowerPoint slide file, and other useful resources are also included as supplemental materials.
Format: Webinar (32:08 minutes)
Description:Treatment of tuberculosis requires multi-drug combination therapy over a sufficient time period and all anti-TB medications are associated with a predictable incidence of adverse effects ranging from mild to severe. This web-based seminar discusses the management of medication side effects in TB patients to decrease the risk of toxicity and ensure completion of therapy.
Format: Webinar (60 minutes)
Organization: Global Tuberculosis Institute (GTBI)
Description: This pocket-size drug treatment information card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in adults, including dosages, daily and intermittent regimens, side effects, treatment information, and visual depictions of first-line medications.
Format: Information card
Description: The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.
Organization:Heartland National Tuberculosis Center (HNTC)
Description: This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with first and second-line TB drugs.
Format: Information Card
Back to Directory
Back to Homepage
© 2017, Rutgers, The State University of New Jersey. All rights reserved.
225 Warren Street, Newark, New Jersey 07103